Glycemic levels and cardiovascular events in type 2 diabetes: A cohort study of drugs with different hypoglycemic potentials

Abstract Research indicates a U-shaped association between mortality and glycated hemoglobin (HbA1c) levels in patients receiving sulfonylurea or insulin. However, the relationship between glucose levels and cardiovascular events in patients on novel agents with a lower hypoglycemic potential remain...

Full description

Bibliographic Details
Published in:	Scientific Reports
Main Authors:	Yi-Cheng Lin, Chih-Wei Chen, Ling-Ya Huang, Bi-Li Chen, Yu-Hsuan Joni Shao, Chun-Yao Huang
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-08-01
Subjects:	Diabetes HbA1c Mortality Major adverse cardiovascular events
Online Access:	https://doi.org/10.1038/s41598-025-10215-7

Similar Items

The role of hemoglobin A1c as a predictor of major adverse cardiovascular events in patients with type 2 diabetes mellitus after percutaneous coronary intervention: a case-cohort study
by: Babak Bagheri, et al.
Published: (2024-10-01)

Long‐Term Visit‐to‐Visit Glycemic Variability as a Predictor of Major Adverse Limb and Cardiovascular Events in Patients With Diabetes
by: Jung‐Chi Hsu, et al.
Published: (2023-02-01)

Metabolic syndrome with mortality and major adverse cardiovascular events in an elderly population
by: Shailendra Kumar Karn, et al.
Published: (2025-05-01)

Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
by: Bao Sun, et al.
Published: (2022-11-01)

Impact of Intensive Glycemic Treatment on Diabetes Complications—A Systematic Review
by: Juliana Poonoosamy, et al.
Published: (2023-06-01)

Integrated metabolic-inflammatory risk assessment: HbA1c/HDL-c and hsCRP-to-albumin ratios synergistically predict major adverse cardiovascular events in post-PCI STEMI patients
by: Jinyong Huang, et al.
Published: (2025-09-01)

Mortality and cardiovascular events in diabetes mellitus patients at dialysis initiation treated with glucagon-like peptide-1 receptor agonists
by: Hsuan-Wen Lai, et al.
Published: (2024-07-01)

Mortality and cardiorenal outcomes among heart failure patients with zinc deficiency: a multicenter retrospective cohort study of 8,290 patients
by: Yu-Min Lin, et al.
Published: (2025-04-01)

Effect of low-dose aspirin on reducing cardiovascular events and mortality in individuals with CKD stages 3–5: a meta-analysis of randomized controlled trials
by: Jingwen Lin, et al.
Published: (2025-04-01)

Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation
by: Yi-Hsin Chan, et al.
Published: (2020-03-01)

Effects of secukinumab and ixekizumab on major adverse cardiovascular events in patients with psoriasis: a meta-analysis of randomized controlled trials
by: Yonghong Zhang, et al.
Published: (2024-03-01)

Risk Factors of Secondary Cardiovascular Events in a Multi-Ethnic Asian Population with Acute Myocardial Infarction: A Retrospective Cohort Study from Malaysia
by: Sophia Rasheeqa Ismail, et al.
Published: (2023-06-01)

Risk of major adverse cardiovascular events and all-cause mortality in type 2 diabetic patients receiving insulin versus non-insulin treatment intensification
by: Yu-Jie Lin, et al.
Published: (2025-08-01)

Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV
by: Kristine M. Erlandson, MD, MS, et al.
Published: (2025-09-01)

Heart Failure Is Associated With Increased Stroke Severity, In‐Hospital Mortality, Major Adverse Cardiovascular Events, and Complications: Insights From the Chinese Stroke Center Alliance
by: Guoliang Hu, et al.
Published: (2025-03-01)

Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
by: Meifan Zheng, et al.
Published: (2020-06-01)

Long-term trajectories of apolipoprotein A1 and major adverse cardiovascular events and mortality in a community cohort
by: Yang Chen, et al.
Published: (2025-04-01)

Sleep Patterns and Traditional Cardiovascular Health Metrics: Joint Impact on Major Adverse Cardiovascular Events in a Prospective Cohort Study
by: Si You, et al.
Published: (2024-05-01)

Prediabetes increases the risk of major limb and cardiovascular events
by: Jung-Chi Hsu, et al.
Published: (2023-12-01)

Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study
by: Junyu Pei, et al.
Published: (2023-10-01)

Comparative efficacy of pharmacological agents on reducing the risk of major adverse cardiovascular events in the hypertriglyceridemia population: a network meta-analysis
by: Yan-yan Qi, et al.
Published: (2021-01-01)

The influence of testosterone on the risk of cardiovascular events after percutaneous coronary intervention
by: Cheng-Hung Chiang, et al.
Published: (2022-12-01)

Glycemic dispersion: a new index for screening high glycemic variability
by: Rui Shi, et al.
Published: (2023-05-01)

Association of glucagon-like peptide-1 receptor agonists with cardiovascular and kidney outcomes in type 2 diabetic kidney transplant recipients
by: Li-Chun Lin, et al.
Published: (2025-02-01)

Association of plasma angiogenin with risk of major cardiovascular events in type 2 diabetes
by: Resham L. Gurung, et al.
Published: (2024-02-01)

Impact of planned concomitant coronary artery bypass grafting on risk of major adverse cardiovascular events in elective aortic hemiarch surgery
by: Bo Chang Brian Wu, et al.
Published: (2025-04-01)

The correlation between protein energy wasting and the incidence of main adverse cardiovascular events in adult maintenance hemodialysis patients: a single-center retrospective cohort study
by: Xiaoyan Ma, et al.
Published: (2025-12-01)

Influence factors and risk assessment model of hyperuricemia complicated with major adverse cardiovascular events
by: GUO Limin, SHI Li, SHE Qimei, GU Guiyan, LI Ailing
Published: (2026-04-01)

Association between Proenkephalin A and cardiovascular outcomes in ambulatory Veterans
by: Shreya Banerjee, et al.
Published: (2024-12-01)

Value of Glycemic Dispersion Index in Predicting Major Adverse Cardiovascular Events in Diabetic Patients with Concomitant Acute Coronary Syndrome
by: Shi R, et al.
Published: (2024-09-01)

Impact of a Medical Fitness Model on Incident Major Adverse Cardiovascular Events: A Prospective Cohort Study of 11 000 Members
by: Ranveer Brar, et al.
Published: (2024-04-01)

Associations between maternal glycemic level and lipid profile and adverse pregnancy outcomes in women with type 2 diabetes mellitus: a retrospective study from China
by: Yiwei Xue, et al.
Published: (2025-06-01)

Impact of Multiple Cardiovascular Events on Long‐Term Outcomes and Bleeding Risk in Patients With Acute Coronary Syndrome: A Nationwide Population‐Based Cohort Study
by: Chih‐Wei Chen, et al.
Published: (2025-07-01)

Major cardiovascular events under biologic psoriasis therapies: a 19-year real-world analysis of FAERS data
by: Lingqing Ding, et al.
Published: (2024-02-01)

Relationship Between Fragmented QRS Complex and Long-Term Cardiovascular Outcome in Patients with Essential Hypertension
by: Mehmet Altunova, et al.
Published: (2022-06-01)

Efficacy of different polypill combinations for primary and secondary cardiovascular disease prevention: a systematic review and meta-analysis
by: Habib Yazgi, et al.
Published: (2025-06-01)

Stock Volatility Increases the Mortality Risk of Major Adverse Cardiovascular Events and Suicide: A Case-Crossover Study of 12 Million Deaths
by: Ya Gao, et al.
Published: (2024-11-01)

Major Adverse Cardiovascular Events in Primary Aldosteronism After Adrenalectomy or Mineralocorticoid Receptor Antagonist Treatment: A Systematic Review and Meta‐Analysis
by: Chien‐Wei Huang, et al.
Published: (2025-02-01)

Waist circumference is associated with major adverse cardiovascular events in male but not female patients with type-2 diabetes mellitus
by: Zhenhua Xing, et al.
Published: (2020-03-01)

Impact of Plasma Exposure of Statins and Their Metabolites With Major Adverse Cardiovascular Events in Chinese Patients With Coronary Artery Disease
by: Xiao-hong Zhou, et al.
Published: (2020-05-01)